Concepedia

Darryl Jones

DJ

Statistics

Publications

8

Citations

698

H-Index

8

Active since

1965

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Novartis (United States)

Darryl Jones is an author at Novartis (Switzerland) specializing in medicinal chemistry, drug discovery, and pharmacology.

Publications per year

1965–2019

8

Publications

8

Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1

Joseph Schoepfer, Wolfgang Jahnke, Giuliano Berellini et al. · Journal of Medicinal Chemistry · 2018 · 447 citations · Full text

, , +14

Antiviral Chemotherapy. I. The Activity of Pyridine and Quinoline Derivatives against Neurovaccinia in Mice

Darryl Jones, Rachel D. Slack, S. Squires et al. · Journal of Medicinal Chemistry · 1965 · 132 citations

, , +11

Nicotinamide Phosphoribosyltransferase Inhibitor as a Novel Payload for Antibody–Drug Conjugates

Alexei S. Karpov, Tinya J. Abrams, Suzanna Clark et al. · ACS Medicinal Chemistry Letters · 2018 · 42 citations · Full text

, , +17

A physical properties based approach for the exploration of a 4-hydroxybenzothiazolone series of β2-adrenoceptor agonists as inhaled long-acting bronchodilators

David T. Beattie, Michelle Bradley, Andrew Brearley et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 27 citations · Full text

, , +16

Discovery of Potent and Selective Antibody–Drug Conjugates with Eg5 Inhibitors through Linker and Payload Optimization

Alexei S. Karpov, Cristina Nieto‐Oberhuber, Tinya J. Abrams et al. · ACS Medicinal Chemistry Letters · 2019 · 16 citations · Full text

, , +17

1–5 of 8